98 related articles for article (PubMed ID: 33656101)
1. Acute porphyrias - A neurological perspective.
Gerischer LM; Scheibe F; Nümann A; Köhnlein M; Stölzel U; Meisel A
Brain Behav; 2021 Nov; 11(11):e2389. PubMed ID: 34661997
[TBL] [Abstract][Full Text] [Related]
2. Case-based discussion of the acute hepatic porphyrias: Updates on pathogenesis, diagnosis and management.
Balwani M; Keel S; Meissner P; Sonderup M; Stein P; Yasuda M
Liver Int; 2024 Apr; ():. PubMed ID: 38618923
[TBL] [Abstract][Full Text] [Related]
3. EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks.
Gouya L; Ventura P; Balwani M; Bissell DM; Rees DC; Stölzel U; Phillips JD; Kauppinen R; Langendonk JG; Desnick RJ; Deybach JC; Bonkovsky HL; Parker C; Naik H; Badminton M; Stein PE; Minder E; Windyga J; Bruha R; Cappellini MD; Sardh E; Harper P; Sandberg S; Aarsand AK; Andersen J; Alegre F; Ivanova A; Talbi N; Chan A; Querbes W; Ko J; Penz C; Liu S; Lin T; Simon A; Anderson KE
Hepatology; 2020 May; 71(5):1546-1558. PubMed ID: 31512765
[TBL] [Abstract][Full Text] [Related]
4. RNA interference therapy in acute hepatic porphyrias.
Yasuda M; Keel S; Balwani M
Blood; 2023 Nov; 142(19):1589-1599. PubMed ID: 37027823
[TBL] [Abstract][Full Text] [Related]
5. Acute hepatic porphyrias - a guide for Hepatologists.
Moghe A; McGuire BM; Levy C
Hepatology; 2024 Apr; ():. PubMed ID: 38607698
[TBL] [Abstract][Full Text] [Related]
6. Biochemical Diagnosis of Acute Hepatic Porphyria: Updated Expert Recommendations for Primary Care Physicians.
Anderson KE; Lobo R; Salazar D; Schloetter M; Spitzer G; White AL; Young RM; Bonkovsky HL; Frank EL; Mora J; Tortorelli S
Am J Med Sci; 2021 Aug; 362(2):113-121. PubMed ID: 33865828
[TBL] [Abstract][Full Text] [Related]
7. Neurology of the acute hepatic porphyrias.
Oliveira Santos M; Leal Rato M
J Neurol Sci; 2021 Sep; 428():117605. PubMed ID: 34375916
[TBL] [Abstract][Full Text] [Related]
8. Neurofilament light chain as a biomarker for acute hepatic porphyrias.
Sgobbi P; Serrano PL; Badia BML; Farias IB; de Oliveira HB; Barbosa AS; Pereira CA; Moreira VF; Pinto ÍFN; Oliveira ASB; Pinto WBVR
Front Neurol; 2024; 15():1384678. PubMed ID: 38715693
[TBL] [Abstract][Full Text] [Related]
9. A case report of acute intermittent porphyria leading to severe disability.
Lin J; Liu J; Wang A; Si Z
Front Neurol; 2023; 14():1334743. PubMed ID: 38274883
[TBL] [Abstract][Full Text] [Related]
10. Brazilian registry of patients with porphyria: REBRAPPO study.
Souza PVS; Afonso G; de Rezende Pinto WBV; de Lima Serrano P; de Mattos Lombardi Badia B; Farias IB; Dos Santos Jorge AC; Machado RIL; Pinto IFN; Barros GB; de Oliveira HB; Calil SR; Franz C; Oliveira ASB
Orphanet J Rare Dis; 2023 Mar; 18(1):49. PubMed ID: 36890577
[TBL] [Abstract][Full Text] [Related]
11. Kidney Involvement in Acute Hepatic Porphyrias: Pathophysiology and Diagnostic Implications.
Ricci A; Guida CC; Manzini P; Cuoghi C; Ventura P
Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943561
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of Neuronal Damage in Acute Hepatic Porphyrias.
Ricci A; Di Pierro E; Marcacci M; Ventura P
Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943446
[TBL] [Abstract][Full Text] [Related]
13. Acute Hepatic Porphyria: Pathophysiological Basis of Neuromuscular Manifestations.
de Souza PVS; Badia BML; Farias IB; Pinto WBVR; Oliveira ASB
Front Neurosci; 2021; 15():715523. PubMed ID: 34646118
[TBL] [Abstract][Full Text] [Related]
14. New Insights into Red Blood Cell Microcytosis upon mTOR Inhibitor Administration.
Jakubowska J; Pawlik B; Wyka K; Stolarska M; Kotulska K; Jóźwiak S; Młynarski W; Trelińska J
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202704
[TBL] [Abstract][Full Text] [Related]
15. Acute hepatic porphyrias for the neurologist: current concepts and perspectives.
Souza PVS; Badia BML; Farias IB; Gonçalves EA; Pinto WBVR; Oliveira ASB
Arq Neuropsiquiatr; 2021 Jan; 79(1):68-80. PubMed ID: 33656101
[TBL] [Abstract][Full Text] [Related]
16. AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
Wang B; Bonkovsky HL; Lim JK; Balwani M
Gastroenterology; 2023 Mar; 164(3):484-491. PubMed ID: 36642627
[TBL] [Abstract][Full Text] [Related]
17. Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives.
Marcacci M; Ricci A; Cuoghi C; Marchini S; Pietrangelo A; Ventura P
Orphanet J Rare Dis; 2022 Apr; 17(1):160. PubMed ID: 35392955
[TBL] [Abstract][Full Text] [Related]
18. RNAi therapy with givosiran significantly reduces attack rates in acute intermittent porphyria.
Sardh E; Harper P
J Intern Med; 2022 May; 291(5):593-610. PubMed ID: 35067977
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
